'Haley and DeSantis have infinitely less to account and apologize for than Trump does'
Frank Bruni in The New York Times
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
'Young voters are ripe for President Biden's taking'
Victor Shi in USA Today
The "hungriest constituency" determines elections, says Victor Shi in USA Today. "Historic" Black turnout lifted Barack Obama to victory, twice. Enthusiastic women voters clinched Hillary Clinton's 2016 Democratic nomination. The group President Joe Biden needs is "young voters." Polls suggest he's losing them, but he isn't. He just needs to make them see his achievements on issues "from climate change to student loan forgiveness to gun violence," and show he can play "hardball" with Republicans.
'Donald Trump and his allies have come up short'
Norman Eisen, Richard W. Painter, and Joyce Vance in The Atlanta Journal-Constitution
The "sensational" allegation of impropriety against Fulton County, Georgia, District Attorney Fani Willis won't let Donald Trump off the hook, say Norman Eisen, Richard W. Painter, and Joyce Vance in The Atlanta Journal-Constitution. One of Trump's Georgia election-subversion co-defendants, GOP operative Michael Roman, claims Willis is romantically involved with the special prosecutor she hired, Nathan Wade. Even if the allegation were true, "a big if," it wouldn't justify Trump's call for dismissal "under Georgia law."
'No one has a God-given right to have someone create "free" new treatments for their disease'
Christopher Jacobs in The Federalist
Pharmaceutical companies responded quickly to Medicare drug price controls Democrats "rammed through," says Christopher Jacobs in The Federalists. The rules give companies limited years to market new medicines before price "negotiation" starts. "Companies whose drugs could treat multiple medical conditions, such as different types of cancer," have started slow-walking some trials to get approval "for the broadest possible condition first," to maximize profits. Patients who need new drugs for rare diseases are the "ultimate losers."
-
August 9 editorial cartoonsCartoons Saturday's political cartoons include snake oil salesmen, Ghislaine Maxwell's new residence, and more
-
5 hastily redrawn cartoons about redistrictingCartoons Artists take on Donald Trump's draughtsmanship, the White House ballroom, and more
-
Bonnie Blue: taking clickbait to extremesTalking Point Channel 4 claims documentary on the adult performer's attention-grabbing sex stunts is opening up a debate
-
DHS preps for major ICE expansion, rankling local law enforcementIN THE SPOTLIGHT As the Trump administration positions ICE as the primary federal police force, its recruitment efforts have been met with a less-than-enthusiastic response
-
'This is a coordinated campaign of harassment'Instant Opinion Opinion, comment and editorials of the day
-
JD Vance rises as MAGA heir apparentIN THE SPOTLIGHT The vice president is taking an increasingly proactive role in a MAGA movement roiled by scandal and anxious about a post-Trump future
-
Congress should 'step in' to block Trump's White House ballroom makeoverInstant Opinion Opinion, comment and editorials of the day
-
Trump's global tariffs take effect, with new additionsSpeed Read Tariffs on more than 90 US trading partners went into effect, escalating the global trade war
-
'America is becoming a nation of homebodies'Instant Opinion Opinion, comment and editorials of the day
-
Eighty years after Hiroshima: how close is nuclear conflict?Today's Big Question Eight decades on from the first atomic bomb 'we have blundered into a new age of nuclear perils'
-
'Discriminating against DACA students'Instant Opinion Opinion, comment and editorials of the day
